Sign in
4

Changes in Ownership

Vanda Pharmaceuticals Inc. Filed Acc 0001209191-21-041496

Director sold 5,000 shares at $19.42 ($97,122)

  • Director acquired 4,015 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Mitchell Stephen Ray Director 2021-06-15 Option exercise +4,015 $10.57 $42,439 14,215 D: show line 1 in the form
Mitchell Stephen Ray Director 2021-06-15 Sale −5,000 $19.42 $97,122 9,215 D: show line 2 in the form
Open-market sales · 5,000 sh · avg $19.42 · $97,122

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Mitchell Stephen Ray Director 2021-06-15 Option exercise · Stock Option (right to buy) −4,015 5,985 D: show line 3 in the form
Loading xslF345X03/doc4.xml…